newsfilter
← Latest News
ACCESS Newswire·

Biophytis Receives Notice of Delisting From Nasdaq and Announces It Will Request a Hearing Before the Nasdaq Hearings Panel

PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / October 27, 2023 / Biophytis SA , , a clinical-stage biotechnology company specialized in the development of